![]() Orexo Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs. | ![]() Celentyx Celentyx is a human immune system focused company specializing in immuno-oncology, inflammation, and autoimmunity in vitro assays. | ||
Founding Date | Founding Date 1996 | Founding Date 1995 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations ID HQ | Locations Uppsala, SE HQ Uppsala, SE Morristown, US | Locations Birmingham, GB HQ Oxford, GB |
Employees | Employees 14,616 | Employees 110 | Employees 12 |
Financial | |||
Revenue (est.) | Revenue (est.) Rp12.8t (FY, 2025) | Revenue (est.) kr26m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods Rp7.7t (FY, 2025) | Cost of goods kr14.5m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit Rp5.2t (FY, 2025) | Gross profit kr18m (FY, 2025) | Gross profit N/A |
Net income | Net income Rp1.2t (FY, 2025) | Net income (kr403.3m) (FY, 2025) | Net income N/A |

Orexo, a specialty pharmaceutical company, engages in the development and commercialization of drugs.
View company
Celentyx is a human immune system focused company specializing in immuno-oncology, inflammation, and autoimmunity in vitro assays.
View company